Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)

Market Cap	16.16B
Revenue (ttm)	4.12B
Net Income (ttm)	445.11M
Shares Out	832.47M
EPS (ttm)	0.53
PE Ratio	36.64
Forward PE	32.90
Dividend	0.22 (1.13%)
Ex-Dividend Date	Jul 14, 2025

Volume	3,332,423
Average Volume	4,269,510
Open	19.30
Previous Close	19.30
Day's Range	19.19 - 19.38
52-Week Range	17.21 - 25.74
Beta	0.54
RSI	41.86
Earnings Date	Oct 29, 2025

About Huaxia Eye Hospital Group

Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis and treatment services for patients with ophthalmic diseases; and myopia prevention and intervention work to the public. It offers services in the areas of cataract, refraction, fundus, strabismus and amblyopia, pediatric ophthalmology, ocular surface, glaucoma, orbital and ocular tumors, and ocular trauma. The company was founded in 2004 and is based in Xiamen, China.

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2004
• Employees: 7,883
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301267

Financial Performance

In 2024, Huaxia Eye Hospital Group's revenue was 4.03 billion, an increase of 0.35% compared to the previous year's 4.01 billion. Earnings were 428.64 million, a decrease of -35.63%.